New approach reduces side effects of high-dose chemotherapy for breast cancer.
D000972:Antineoplastic Agents, Phytogenic / Q000008:administration & dosage* / Q000009:adverse effects / Q000097:blood; D001943:Breast Neoplasms / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D004305:Dose-Response Relationship, Drug; D064420:Drug-Related Side Effects and Adverse Reactions / Q000517:prevention & control*; D005260:Female; D006801:Humans; D017239:Paclitaxel / Q000008:administration & dosage* / Q000009:adverse effects / Q000097:blood; D011379:Prognosis
D000972:Antineoplastic Agents, Phytogenic; D017239:Paclitaxel